Last update 19 Jun 2024
NaPi-2b x P-gp x SLC20A1 x SLC20A2
Sodium-dependent phosphate transport protein 2B x P-glycoprotein 1 x solute carrier family 20 member 1 x solute carrier family 20 member 2
Last update 19 Jun 2024
Related
Target |
Mechanism |
Active Org. |
Originator Org. |
Active Indication |
Inactive Indication |
Drug Highest Phase |
First Approval Ctry. / Loc. |
First Approval Date |
一项在接受维持性血液透析的慢性肾脏病高磷血症患者中评价AP-306安全性和血清磷降低作用的II期、随机、开放、阳性药物对照、多中心研究
[Translation] A Phase II, randomized, open-label, active-controlled, multicenter study to evaluate the safety and serum phosphorus-lowering effect of AP-306 in patients with chronic kidney disease and hyperphosphatemia receiving maintenance hemodialysis
A Phase 2, Randomized, Open-Label, Active-Controlled, Multicenter Study to Evaluate the Safety and Serum Phosphorus Lowering Effect of AP-306 in Chronic Kidney Disease Patients Receiving Maintenance Hemodialysis With Hyperphosphatemia
100 Clinical Results associated with NaPi-2b x P-gp x SLC20A1 x SLC20A2
Login to view more data
100 Translational Medicine associated with NaPi-2b x P-gp x SLC20A1 x SLC20A2
Login to view more data
Login to view more data
Analysis
Perform a panoramic analysis of this field.
login
or
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Leverages most recent intelligence information, enabling fullest potential.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free